GILD vs SINT · P/E 18, rev $7.80B vs rev $832.0K
Gilead Sciences Inc (GILD) versus SINTX Technologies Inc (SINT) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
SINTX Technologies Inc (SINT) is a medical devices company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported SINT revenue for 2026-06-30 was $832.0K. Net income was -$5.5M. SINT currently screens at market cap $12.6M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. SINT currently screens at market cap $12.6M.
Not investment advice. Open the GILD and SINT stock pages for the full models.
Not investment advice.